Press releases
-
ICON reports second quarter 2023 results
Net business wins in the quarter of $2,419 million; a net book to bill of 1.20 or 1.21 on a trailing twelve month basis.
-
ICON recognised for CRO excellence
Industry awards as an employer of choice and for its creative and digital services.
-
ICON plc schedules second quarter 2023 earnings conference call
ICON plc will release its financial results for the second quarter 2023 after the market closes on Wednesday, July 26, 2023
-
ICON releases latest version of its Digital Platform
ICON plc today announced the latest release of its Digital Platform.
-
ICON plc set to join Russell 3000® Index
ICON plc is set to join the broad-market Russell 3000® Index at the conclusion of the 2023 Russell indexes annual reconstitution. -
ICON plc to attend upcoming investor conferences
ICON plc today announced that Dr. Steve Cutler, CEO of ICON plc, will present at the William Blair 43rd Annual Growth Stock Conference and Mr. Brendan Brennan, CFO of ICON plc, will attend the UBS Healthcare Services Conference.
-
ICON releases its 2022 ICON Cares ESG report
ICON announced the release of its ICON Cares 2022 Environmental, Social and Governance (ESG) Report.
-
ICON reports first quarter 2023 results
Revenue for the first quarter was $1,978.6 million. This represents an increase of 4.0% on prior year revenue or 5.3% on a constant currency organic basis.
-
ICON plc schedules first quarter 2023 earnings conference call
ICON plc today announced that it will release its financial results for the first quarter 2023.
-
LEO Pharma and ICON enter a strategic partnership to propel clinical trial execution within medical dermatology
Leo Pharma Group and ICON plc today announced a strategic partnership to improve dermatology patients' lives through innovative clinical trials.
